Research Article
Antimicrobial Resistance Patterns in Patients with Vaginal Discharge: A 2019-2022 Analysis at the National Health Laboratory in Eritrea
Table 2
Antimicrobial sensitivities to different antibiotics from vaginal swab isolates in the National Health Laboratory.
| | Antibiotics tested | Antimicrobial sensitivity, frequency (percent), (170) | Total (%) | | Intermediate | Resistant | Sensitive |
| | Amikacin | 26 (19.5) | 11 (8.3) | 96 (72.2) | 133 (100.0) | | Ampicillin | 14 (10.1) | 98 (71.0) | 26 (18.8) | 138 (100.0) | | Cephalexin | 51 (38.3) | 41 (30.8) | 41 (30.8) | 133 (100.0) | | Ceftazidime | 9 (6.8) | 20 (15.0) | 104 (78.2) | 133 (100.0) | | Ceftriaxone | 7 (5.3) | 21 (15.8) | 105 (78.9) | 133 (100.0) | | Nalidixic acid | 13 (9.8) | 32 (24.1) | 88 (66.2) | 133 (100.0) | | Chloramphenicol | 3 (1.8) | 26 (15.3) | 141 (82.9) | 170 (100.0) | | Ciprofloxacin | 13 (7.9) | 29 (17.6) | 123 (74.5) | 165 (100.0) | | Co-trimoxazole | 7 (4.4) | 78 (48.8) | 75 (46.9) | 160 (100.0) | | Gentamicin | 23 (13.9) | 41 (24.7) | 101 (60.8) | 166 (100.0) | | Nitrofurantoin | 13 (8.1) | 27 (16.8) | 120 (74.5) | 161 (100.0) | | Tetracycline | 5 (3.0) | 88 (52.1) | 76 (45.0) | 169 (100.0) | | Clindamycin | 8 (25.0) | 3 (9.4) | 21 (65.6) | 32 (100.0) | | Erythromycin | 9 (24.3) | 13 (35.1) | 15 (40.5) | 37 (100.0) | | Oxacillin | 3 (9.4) | 18 (56.3) | 11 (34.4) | 32 (100.0) | | Penicillin G | 0 (0) | 24 (88.9) | 3 (11.1) | 27 (100.0) | | Rifampicin | 0 (0) | 5 (15.6) | 27 (84.4) | 32 (100.0) | | Vancomycin | 0 (0) | 20 (54.1%) | 17 (45.9) | 37 (100.0) |
|
|
